Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Imidazole-based protein farnesyltransferase inhibitors for cancer

June 1, 1999

More on protein farnesyltransferase inhibitors in development at Merck

June 1, 1999

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

June 1, 1999

Recombinant enzyme plus gene therapy: a unique combination therapy for cancer

May 31, 1999

CPMP recommends expanded approval of Temodal for brain tumor therapy

May 31, 1999

Ilex initiates clinical testing of vitamin D3 analogue

May 31, 1999

EntreMed announces sites for Endostatin phase I clinical trials

May 31, 1999

More news from ASCO: safety and pharmacokinetics of squalamine examined in phase I trials

May 28, 1999

Survival advantage for exemestane observed in phase III breast cancer trial reported at ASCO meeting

May 28, 1999

DNA ligase inhibitors with alpha-pyrone structure in development at Millennium

May 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...